Achillion Pharmaceuticals (ACHN)
Add to Watchlists Create an AlertACHN Key Stats
| Income Statement | |
| Revenue TTM | 0.118M |
| Revenue Quarterly YoY Growth | -100.0% |
| EPS Diluted TTM | -0.6408 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -49.72M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 731.90M |
| Enterprise Value | 587.52M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 3.753 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.0031 |
| Free Cash Flow | -13.31M |
| Return on Equity | -53.34% |
ACHN News
- Nasdaq stocks posting largest percentage decreases May 22
- Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, Ma... May 21
- 7 Biotechnology Stocks to Sell Now Investor Place May 15
- The Young And Restless Retirement Portfolio: Stay The Course Seeking Alpha May 15
- Achillion Names Dr. David Apelian CMO Benzinga May 15
- Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinic... May 15
- Achillion: Down But Not Out And Progress Being Made May 10
- Achillion to Present at Three Upcoming Investor Conferences GlobeNewswire May 9
- 7 Biotechnology Stocks to Sell Now Investor Place May 8
- ACHILLION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 7
ACHN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Achillion Pharmaceuticals is up 3.55% over the last year vs S&P 500 Total Return up 27.77%, Acorda Therapeutics up 44.17%, and Discovery Laboratories down 38.46%.
ACHN Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ACHN related companies
Pro Ratings for ACHN
Pro Report PDF for ACHN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download ACHN Pro Report PDF
Pro Strategies Featuring ACHN
Did Achillion Pharmaceuticals make it into our Pro Portfolio Strategies?
ACHN Profile
Sector: Healthcare
Industry: Biotechnology
Other ACHN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ACHN | 7.58 | -0.06 | -0.79% | 731.90M |
